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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S147oxoguanine DNA glycosylase (Ogg1) repairs the 8-oxoguanine, one of the
most abundant DNA adducts caused by oxygen free radicals. This study
identiﬁed mitochondrial Ogg1 as a pathogenic mechanism in response to
catabolic factors in osteoarthritis (OA).
Methods: 8-oxoguanine and Ogg1 expressions were investigated in
human OA cartilage and rat OA cartilage by immunohistologic analysis. We
studied whether OA-related catabolic factors inﬂuence expression of Ogg1
or 8-oxoguanine in OA chondrocytes and analyzed the relationship among
cellular function, apoptosis and Ogg1 or 8oxoguanine expression in human
chondrocytes.
Results: We observed the increased level of 8-oxoguanine and the
decreased level of Ogg1 in OA chondrocytes in comparison with normal
chondrocytes in OA rats as well as in patients with OA. OA-related catabolic
factors induced the overexpression of 8-oxoguanine and down-regulation
of Ogg1 in chondrocytes. We found that overexpression of mitochondria
Ogg1 in OA chondrocytes prevents catabolic stress-induced mitochondrial
dysfunction, caspase-9 activation and apoptosis in vitro. Furthermore,
Ogg1 silencing using siRNA reduced chondrocyte activity and augments
apoptosis in OA chondrocytes.
Conclusions: The accumulation of an oxidized form of guanine, 8-oxo-
guanine, and down-regulation of its repair enzyme Ogg1 in OA chon-
drocytes may be involved in the pathogenesis of OA. Our study suggests
that Ogg1 prevents catabolic stress-mediated chondrocyte dysfunction
and apoptosis that might be associated with the maintenance of articular
cartilage.
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PHYSIOLOGICAL CONCENTRATIONS OF GLUCOSAMINE SULFATE AND
GLUCOSAMINE HCL CAN DOWNREGULATE INTERLEUKIN-1, KININS
AND MMPS IN HUMAN OSTEOARTHRITIC CHONDROCYTES
W. Wu, M. Pasierb. Henry Ford Hosp., Detroit, MI, USA
Purpose: Glucosamine (GLN) products are taken by patients suffering
fromOA and other joint problems. In the United States it sold in the form of
Glucosamine HCL (GHCl) as a nutritional supplement, while in Europe it is
prescribed in the Glucosamine Sulfate (GS) form. In clinical trials both in
the US and Europe has shown that GLN can reduce pain scores in patients
with moderate to severe knee pain. Although GLN may be beneﬁcial, their
exact mechanism of action(s) remains obscure. Also because of the two
different forms used, there is still controversy to which form of GLN is
more effective. To further elucidate their mechanism of action, we deter-
mined the effects of both forms GLN at concentrations attainable in vivo
and lower than those reported in in vitro studies, on selected pain medi-
ators, inﬂammatory mediators, collagenases MMP-1 and MMP-13 using
cytokine-stimulated human chondrocyte cultures.
Methods: We took advantage of the recent pharmacokinetic information
of GLN concentrations in plasma and synovial ﬂuid to conduct our studies.
Human (n¼3) OA chondrocytes (ages: 53, 59 & 62) were isolated from
cartilage obtained from total knee arthroplasty. Chondrocytes were seeded
at 0.5 X 106 cells/ml and cultured in the presence of DMEM plus 10% FBS for
48h. Pharmaceutical grade GS and GHCl were provided as kind gifts from
Bioiberica, SA, Spain. The chondrocytes were then serum starved for 24h
and treated with either of the following: Control (Ctrl), 5 ng/ml human
recombinant IL-b (IL-1), 0.5mg/ml GS, 5.0mg/ml GS, 0.5mg/ml GHCl, 5.0mg/
ml GHCl, IL-1 + 0.5mg/ml GS, IL-1 + 5.0 mg/ml GS, IL-1 + 0.5mg/ml GHCl or IL-
1 + 5.0 mg/ml GHCl. Cells and media were collected 48h after stimulation.
Total RNA was isolated from cells. Semi-quantative RT-PCR was uses to
assess gene expression for Kininogen, IL-1b, IL-1b receptor, MMP-1 and
MMP-13. Proteins of MMP-1 and MMP-13 secreted into the media were
measured by Western blot. Gene and Western blot data were analyzed
statistically using the student t-test. Different letters within a parameter
indicate signiﬁcant differences (P <0.05) differences between treatments.
Results: As expected, the addition of 5ng/ml of IL-1b stimulated the mRNA
expression of IL-1b, IL-1 receptor, Kininogen, MMP-1 and MMP-13 in the
OA chondrocytes. Chondrocytes cultured in the preseence of 0.5GS, 5.0 GS,
0.5 GHCl and 5.0 GHCl were all able to down-regulate the mRNA expres-
sion of these genes signiﬁcantly. In most cases, both the GS and GHCl were
able to repress expression to or below control levels. Western blotting of
MMP-1 and MMP-13 conﬁrmed gene expression data at the protein level.
Both GS and GHCl decreased the protein abundance of cytokine stimulatedMMP-1 and MMP-13. The addition of GS showed more potency as
compared to GHCl at the same concentrations in suppressing the gene
expression of these mediators.
Conclusions: The most common symptom and complaint of OA patients
is joint pain which often increases in severity until the only clinical
option is total joint arthroplasty. Despite the central position of pain in
the progression and management of OA, little is known about the causes
of OA pain. Pain receptors are present in cartilage but the functional
signiﬁcance of their presence is not known. A possibility may be the
generation of soluble pain mediators that migrate to adjacent tissues to
elicit an effect. Pain mediators in cartilage may also play a role in cartilage
degradation. Low grade inﬂammation occurs in OA resulting in joint pain.
The addition of both forms of GLN was effective in depressing expression
of Kininogen, IL-1b and its receptor. This would indicate that GLN can
downregulate inﬂammatory effects such as further inﬂammation, pain
and cartilage matrix turnover. The concentration of GLN at 0.5mg/ml is
about 6 times lower than that found in human serum after GLN ingestion.
More studies that investigate the signaling cascade involved in this
regulation of pain mediators, inﬂammatory cytokines and MMPs will
allow us to understand the molecular action of GLN in OA pain and as
a treatment for OA.
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MIMICKING THE RESPIRATORY BURST MYELOPEROXIDASE SYSTEM OF
POLYMORPHONUCLEAR NEUTROPHIL GRANULOCYTES TO AID THE
WOUND HEALING BEHAVIORS OF ARTICULAR CARTILAGE
W.K. Augé, II. NuOrtho Surgical, Inc., Fall River, MA, USA
Purpose: Articular cartilage exhibits a limited ability to remove damaged
tissue from its surfaces, a step integral for efﬁcient mammalian wound
healing that is typically enabled by polymorphonuclear neutrophil gran-
ulocytes in other tissue types. This limited ability constrains articular
cartilage wound healing behaviors, contributing to lesion progression and
the disease burden of osteoarthritis. The respiratory burst myeloperox-
idase system of polymorphonuclear neutrophil granulocytes produces low
stability protonating agents involved in exothermic tissue homeostasis and
repair mechanisms through disproportionation redox reactions. Because
these protonating agents facilitate the removal of damaged interstitial
matrices through biopolymer disaggregation in order to assist differenti-
ated tissue assembly activities, this study evaluates the capability of
alternating current redoxmagnetohydrodynamic technology tomimic this
respiratory burst to aid the wound healing behaviors of articular cartilage
by creating a healthy lesion site devoid of damaged tissue.
Methods: An alternating current redox magnetohydrodynamic device
fashioned as a physiochemical scalpel was deployed in 0.9% sodium
chloride solutions at 300 mOsm/L and at 20oC. Figure 1 demonstrates the
device producing solution changes that are delivered to tissue surfaces as
